Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income Corporation (NYSE: O) closed this week with investors balancing two fresh, shareholder-friendly headlines—a new dividend increase and a headline-grabbing $800 million preferred equity investment in CityCenter Las Vegas—against the bigger force that still tends to steer net-lease REITs:
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Nike, Inc. (NYSE: NKE) heads into next week with its biggest near-term catalyst on the calendar: fiscal Q2 2026 earnings on Thursday, Dec. 18 (after the close). Nike Investor Relations After a volatile
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58
Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers Group, Inc. (Nasdaq: IBKR) closed Friday, Dec. 12 at $64.15, ending a volatile session down about 2.9% after swinging from roughly $66.00 at the high to $62.58 at the low. StockInvest The week’s price action landed as investors
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)HCA Healthcare, Inc. (NYSE: HCA) closed Friday at $484.77, finishing the week essentially flat—but not quiet. A sharp midweek drop and quick rebound put policy risk, reimbursement headlines, and year-end positioning back in the
Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin Corporation (NYSE: LMT) wrapped up the week with a strong move higher, closing at $480.25 on Friday, December 12, 2025, extending a nine-session winning streak even as broader U.S. equities finished the day lower. MarketWatch+1 For investors tracking
CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025Company: CME Group Inc. (NASDAQ: CME) CME Group stock ended the week on a steadier footing after a midweek dip, closing at $273.55 on Friday, Dec. 12 (up 0.42% on the day). Finviz That finish capped
13 December 2025
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025 (U.S. market close) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) finished Friday at $452.04, extending a late-week rebound after a choppy start to the week. The stock’s intraday range on Friday stretched from $442.94 to $455.99 on volume
1 108 109 110 111 112 296
Go toTop